Last updated: January 30, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ear Infections
Treatment
Transcanal Endoscopic removal of atticoantral cholesteatoma
Clinical Study ID
NCT06246682
Soh-Med-24-01-03MD
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients presenting with primary acquired localized atticoantral cholesteatoma.
Exclusion
Exclusion Criteria:
- Age group: patients below 12 years old.
- Patients presenting with congenital or secondary acquired cholesteatoma.
- Patients presenting with extensive, residual, or recurrent cholesteatoma.
- Patients with craniofacial anomalies.
Study Design
Total Participants: 25
Treatment Group(s): 1
Primary Treatment: Transcanal Endoscopic removal of atticoantral cholesteatoma
Phase:
Study Start date:
February 10, 2024
Estimated Completion Date:
March 22, 2026
Study Description
Connect with a study center
faculty of medicine Sohag university
Sohag, 1670005
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.